International Journal of Prostate Cancer

Aims and Scope

International Journal of Prostate Cancer (IJPC) is a peer-reviewed, open-access journal dedicated to advancing research and clinical knowledge in all aspects of prostate cancer. IJPC serves as a global platform for researchers, clinicians, and healthcare professionals to share cutting-edge discoveries in prostate cancer detection, diagnosis, management, and treatment.  
 

Scope & Areas of Focus: IJPC covers a wide range of topics, including but not limited to:  

• Molecular Biology & Genetics: Exploring the genetic and molecular mechanisms of prostate cancer.  
• Epidemiology & Pathogenesis: Investigating risk factors, disease progression, and prevention strategies.  
• Diagnostic Innovations: Advancements in biomarkers, imaging, and early detection methods.  
• Clinical & Surgical Treatments: Novel approaches in surgery, and chemotherapy.  
• Radiologic Imaging & Radiation Therapy: Cutting-edge research in prostate cancer imaging and targeted radiotherapy.  
• Pharmacology & Immunology: Development of new drugs, immunotherapies, and precision medicine.  
• IJPC pioneers Artificial Intelligence-driven research, precision therapies, and innovations for advanced prostate cancer detection and treatment.
• Psychosocial & Economic Impact: Understanding the social, psychological, and financial burdens of prostate cancer.  

Below is the list of topics covered to the journal. However, if you could not find the topic of your interest. Please feel free to contact us at [email protected]
 

• Erectile dysfunction
• Hormone therapy
• Angiogenesis
• Brachytherapy
• Endocrinologists
• Alternative therapies
• Photodynamic therapy
• Anatomy
• Oncologists
• Prostatic hyperplasia
• Physiology
• Genomics
• Androgen deprivation therapy
• Pathologists
• Screening for prostate cancer
• Endocrinology
• Prostate-specific antigen
• Biochemists
• Quality of life issues
• Physiologists
• Conformal radiotherapy
• Familial prostate cancer
• Gene therapy for prostate cancer
• Prognostic markers
• Recurrence after radical prostatectomy
• Percent-free psa
• Biochemical studies
• Embryology
• Radical retropubic prostatectomy
• Tumor suppressor gene
• Urologists
• Abiraterone acetate
• Androgen receptor
• Benign prostatic hyperplasia
• Bicalutamide
• Cabazitaxel
• Cancer prevention
• Degarelix
• Docetaxel
• Enzalutamide
• External beam radiation
• Goserelin acetate
• Leuprolide acetate
• Lymph node
• Male reproductive system
• Prostate cancer
• Radium 223 dichloride
• Tumor cell
• Prostatitis
• Adjuvant therapy
• Serum psa
• Transrectal ultrasound
• Digital rectal examination
• Flutamide
• Progestogenic properties
• Antiandrogens
• Radical prostatectomy